ALPS醫藥突破ETF SBIO 深 滬
已收盤 10-31 16:00:00 美东时间
45.135
+0.435
+0.97%
華盛通- 最 高45.1903
- 今 開44.79
- 成交量 1.30万股
- 最 低 44.46
- 昨 收 44.70
- 總市值 1.22亿
- 52周最高 45.26
- 市盈率 靜 --
- 換手率 0.48%
- 52周最低 22.33
- 委 比 0.00%
- 總股本 270.00万
- 歷史最高 62.7955
- 量 比 0.62
- 振 幅 1.63%
- 歷史最低 16.5561
- 每 手 1
- 風險率 4.25%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Sabio Holdings announces $4M brokered private placement
Sabio Holdings (TSXV:SBIO:CA) (OTCQB:SABOF) launched a brokered private placement of common shares. Canaccord Genuity Corp. will act as lead agent and sole bookrunner on a ‘best efforts’ fully markete...
10-24 04:55
Sabio’s Creator Television® Wins Prestigious ‘Most Significant Newcomer’ Award
Sabio Holdings ( ($TSE:SBIO) ) has issued an update. Sabio Holdings’ Creator Te...
10-22 07:38
Sabio Holdings’ Creator Television Launches ‘Creator Poker Championship’ with World Poker Tour®
Sabio Holdings ( ($TSE:SBIO) ) has provided an announcement. Sabio Holdings’ Cr...
10-10 03:08
Sabio Holdings Celebrates Hispanic Heritage Month with Special Programming
Sabio Holdings ( ($TSE:SBIO) ) just unveiled an update. Sabio Holdings announce...
09-17 05:43
Kalaris Reports Second Quarter 2025 Financial Results and Provides Business Updates
Kalaris Therapeutics is enrolling treatment-naïve nAMD patients in a Phase 1 trial of TH103, a novel anti-VEGF agent designed for longer-lasting efficacy, with initial data expected in Q4 2025. The company reported $88.4M in cash as of June 2025, sufficient for operations into Q4 2026. Quarter-over-quarter increases in R&D and G&A expenses reflect ongoing clinical activities. Kalaris expanded its leadership with Kristine Curtiss as Senior Vice Pr...
08-13 12:00
Sabio Holdings Expands Creator TV Reach with Xumo Partnership
An announcement from Sabio Holdings ( ($TSE:SBIO) ) is now available. Sabio Hol...
08-01 07:38
Sabio Holdings Proposes Shares-for-Debt Transaction to Settle Interest
Sabio Holdings ( ($TSE:SBIO) ) has shared an update. Sabio Holdings has announc...
08-01 07:37
Sabio Expands Creator Television® Reach with Xumo Partnership
Sabio Holdings ( ($TSE:SBIO) ) has provided an update. Sabio Holdings has launc...
06-27 04:42
Standard BioTools to Host Inaugural “Proteomics Roundtable” Webcast Series
Standard BioTools Inc. has launched its inaugural Proteomics Roundtable Series, a virtual event program aimed at advancing discussions in the field of proteomics. The series features leading researchers and experts sharing insights on breakthroughs, technological developments, and real-world applications impacting healthcare. The first session, "Is More Really More? Evaluating the Case for High-Plex, High-Quality Proteomics," takes place on June ...
05-30 11:00
Sabio’s Creator TV Named 2025 StreamTV Award Finalist
Sabio Holdings ( ($TSE:SBIO) ) has issued an update. Sabio Holdings announced t...
05-15 01:39
